Evidence mapPaperPMID 39458516Full record

ArticleNutrients2024

Therapeutic Effects of

Woo-Gyun Choi, Seok-Jae Ko, Daehwa Jung, Sang Chan Kim, Na-Ri Choi, Jae-Woo Park, Byung Joo Kim

Abstract read
In one paragraph

Article in Nutrients, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Woo-Gyun ChoiDepartment of Longevity and Biofunctional Medicine, Pusan National University School of Korean Medicine, Yangsan 50612, Republic of Korea.ORCID 0000-0003-4689-6394
Seok-Jae KoDepartment of Clinical Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Daehwa JungDepartment of Pharmaceutical Engineering, Daegu Hanny University, Gyeongsan 38610, Republic of Korea.
Sang Chan KimCollege of Oriental Medicine, Daegu Haany University, Gyeongsan 38610, Republic of Korea.ORCID 0000-0003-0515-0764
Na-Ri ChoiDepartment of Longevity and Biofunctional Medicine, Pusan National University School of Korean Medicine, Yangsan 50612, Republic of Korea.ORCID 0000-0003-2564-1720
Jae-Woo ParkDepartment of Clinical Korean Medicine, Graduate School, Kyung Hee University, Seoul 02447, Republic of Korea.
Byung Joo KimDepartment of Longevity and Biofunctional Medicine, Pusan National University School of Korean Medicine, Yangsan 50612, Republic of Korea.

Funding

This study was financially supported by the 2024 Post-Doc. Development Program of Pusan National University and by Basic Science Research Program through the National Research Foundation of Korea (NRF), funded by the Ministry of Education 2021R1I1A3042479
6 · The paper itself

Abstract

(1) Background: IBD (inflammatory bowel disease) is characterized by chronic intestinal inflammation leading to persistent symptoms and a lack of effective treatments. ZP (

Indexed as

Anti-Inflammatory AgentsAntioxidantsColitisDextran SulfateDisease Models, AnimalDrugs, Chinese HerbalAnimalsColonCyclooxygenase 2Inflammatory Bowel DiseasesMaleMedicine, Chinese TraditionalMiceMice, Inbred C57BLNetwork PharmacologyNitric Oxide Synthase Type II3-nitrotyrosineAnti-Inflammatory AgentsAntioxidantsCyclooxygenase 2Dextran SulfateDrugs, Chinese HerbalNitric Oxide Synthase Type IINos2 protein, mousePPAR gammaPparg protein, mousePtgs2 protein, mouseReceptors, G-Protein-CoupledTyrosinecolitisdextran sodium sulfateinflammatory bowel diseasenetwork pharmacologicaltraditional Chinese medicineZanthoxyli Pericarpium

Identifiers

PMID39458516
PMCPMC11510417

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.